Form 483 Archives - Page 2 of 2 - Express Pharma

US FDA issues warning to Mylan for Telangana plant

Alembic Pharma receives four observations from USFDA for Panelav facility

Alkem Labs gets EIR from US FDA for Baddi facility

Biocon gets three observations from US health regulator for Malaysia facility

USFDA issues Form 483 with five observations to Biocon’s Bengaluru facility

USFDA inspects Alembic Pharma’s facility in Karkhadi

Dr Kiran Mazumdar-Shaw honoured with Australia’s highest civilian honour

US FDA issues three observations to Ipca Laboratories Silvassa unit

US FDA completes audit of Dr Reddy’s Louisiana-based facility

USFDA issues 12 observations for three Biocon units in Malaysia